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Varicella-zoster virus (VZV) is responsible for chickenpox
On the basis of analogy to the prototypic virus herpes simand shingles. It also produces verrucous, longstanding cutaplex virus (HSV), the VZV replicative cycle is supposed to be neous lesions in human immunodeficiency virus (HIV)-inregulated in a cascade of three successive steps involving the fected persons [1] [2] [3] [4] [5] [6] [7] [8] [9] . Such lesions are frequently associated immediate early, early, and late phases. The IE63 protein is with acyclovir resistance, which may be due to multiple, nonpresent in the nuclear and perinuclear area of keratinocytes in uniform mutations in the thymidine kinase gene [7] . The cause full-blown VZV skin lesions of immunocompetent and HIVof epidermal hyperplasia and chronicity of the lesions is uninfected individuals [10] . The ORF 68-and ORF 33-encoded known; however, it has been hypothesized that the VZV gene major glycoproteins gE and gB have also been demonstrated expression could be altered [8] .
in the cell membranes and cytoplasm of keratinocytes. During viral latency, IE63 expression has been detected in infected ganglionic neurons in rats [11, 12] and humans [13] ; however, gE expression was lacking in the animal model [11] . Using light microscopy, immunohistochemistry, and in situ cleated syncytial giant cells with ground glass-appearing nu-Immunohistochemistry. Immunohistochemistry was done usclei, and cytolysis of infected keratinocytes). No differences ing the rabbit polyclonal antibody anti-IE63 [11] and the murine were noted between vesicular lesions in HIV-infected and immonoclonal antibodies VL8 and VL2, which were directed to the munocompetent persons.
VZV glycoproteins gE and gB, respectively, as previously reported
Immunohistochemistry. The results of the semiquantitative [14, 15] . A semiquantitative approach using various primary antiassessment of the gE and gB glycoproteins and of the IE63 body dilutions (VL8 and VL2 antibodies undiluted, 1/10, 1/20, protein are summarized in table 1. The pattern of IE63 immunoand 1/40) was used to evaluate differences in gE and gB signal staining was predominantly nuclear and occasionally cytostrength. Immunohistochemical signals were rated as strong (//), plasmic (figure 1). When present, the gE and gB signals were weak (/), or nondetectable (0). Serial sections were prepared for most often seen in membranes of infected keratinocytes and immunohistochemistry and in situ hybridization methods to study the signal localization of the VZV proteins and nucleic acids, more sporadically in the cytoplasm. Immunolabeling using the respectively. Control slides were identically treated.
anti-IE63, VL8, and VL2 antibodies or normal rabbit serum In situ hybridization. Skin sections were assessed by in situ instead of primary antibodies on normal skin samples and HSV hybridization for the presence of VZV nucleic acids. The assays skin sections was consistently negative.
were done according to a previously published protocol [14] using In situ hybridization. Table 1 summarizes hybridization signals were present in the same keratinocytes. Probe omission and in situ hybridization on normal skin and and humans [13] . Therefore, VZV infection in keratinocytes appears to encompass a wide spectrum of biologic and clinical HSV skin lesions were negative.
presentations. The expression of this spectrum seems, at least in part, to be dependent on the production rate of VZV late proteins, which ranges from nondetectable to high, as observed Discussion in the productive stage of infection. Besides having a variable degree of hyperkeratosis, parakeratosis, and acanthosis, warty, long-standing VZV skin lesions
